Taste Evaluation by Electronic Tongue and Bioavailability Enhancement of Efavirenz

2019 ◽  
Vol 20 (2) ◽  
Author(s):  
Monica R. P. Rao ◽  
Kirti Bhutada ◽  
Pauroosh Kaushal
Author(s):  
Marina Delanni Vitória Guedes ◽  
Morgana Souza Marques ◽  
Pablo Cristini Guedes ◽  
Renata Vidor Contri ◽  
Irene Clemes Kulkamp Guerreiro

Molecules ◽  
2019 ◽  
Vol 24 (14) ◽  
pp. 2574 ◽  
Author(s):  
Mabuchi ◽  
Ishimaru ◽  
Adachi ◽  
Zhao ◽  
Kikutani ◽  
...  

We performed metabolic profiling on yellowtail (Seriola quinqueradiata) muscle to develop an objective taste evaluation method for fish meat. Dark (DM) and ordinary (OM) muscle samples before and after storage were subjected to gas chromatography-mass spectrometry (GC-MS) analysis and taste measurements using an electronic tongue. The metabolites identified by the GC-MS analysis were treated as x variables, and the taste values obtained by the electronic tongue were treated as y variables. The relationships between the metabolites and taste attributes were evaluated by two-way orthogonal projections to latent structures (O2PLS) analysis. The O2PLS analyses were normalized in two ways, unit variance (UV) and pareto (Par) scaling. The O2PLS (UV) analysis produced 3+1+0 models in Autofit and this model was statistically significant with R2Y (0.73) and Q2 (0.52) metrics. In particular, significant correlations were found between DM or OM and metabolite intensity and taste attributes, and strong associations were found between “sourness” and lysine, “irritant” and alanine and phenylalanine, “saltiness” and pantothenic acid, and “umami” and creatinine and histidine. The O2PLS (Par) analysis of DM generated significant predictive models for “acidic bitterness,” “irritant,” “saltiness,” “bitterness,” “astringency,” and “richness.” Among these, only “irritant” was affected by storage. This method was thus effective in evaluating the taste of yellowtail muscle.


2009 ◽  
Vol 136 (1) ◽  
pp. 209-217 ◽  
Author(s):  
L.A. Dias ◽  
A.M. Peres ◽  
A.C.A. Veloso ◽  
F.S. Reis ◽  
M. Vilas-Boas ◽  
...  

2017 ◽  
Vol 8 (1and2) ◽  
pp. 98-102
Author(s):  
BHUPINDER SINGH ◽  
PRIYANKA HANDA

2017 ◽  
Vol 23 (4) ◽  
pp. 27-34
Author(s):  
Pyong in Lee ◽  
Jung hwan Kwon ◽  
Young kyoung Yi
Keyword(s):  

2016 ◽  
Vol 13 (4) ◽  
pp. 611-620 ◽  
Author(s):  
Neha V. Bhilare ◽  
Suneela S. Dhaneshwar ◽  
Akanksha J. Sinha ◽  
Amit D. Kandhare ◽  
Subhash L. Bodhankar

2017 ◽  
Vol 7 (3) ◽  
Author(s):  
Akhlesh K. Jain ◽  
Parasuraman Mohan ◽  
Sunil K. Jain ◽  
Karthikeyan Kesavan

2020 ◽  
Vol 10 (4) ◽  
pp. 255-277
Author(s):  
Shashank Chaturvedi ◽  
Raghav Mishra

: Formulation development of BCS Class II and IV drugs is a challenging task due to their poor solubility and permeability issue. : An extensive literature survey was conducted to explore the relevant pharmaceutical approaches that have been used for solving the issue of poor solubility and permeability in the recent past. : It has been found that a plethora of approaches have been investigated for addressing the issue of poor solubility and or permeability. These include physical modifications (modification of crystal habit, particle size reduction, complexation, polymorphism and drug dispersion in carriers), chemical modifications (salt formation), and formulation modifications (Nanotechnology-based approaches and hydrotropy). : The physical and chemical modification approaches can be effectively used to enhance the solubility and dissolution rate of poorly soluble drugs, but the additional problem of poor permeability has been better addressed by lipid-based drug delivery systems. As the latter presents the drug in the solubilized state, bypass first-pass effects, circumvent the effect of Para-glycoprotein mediated efflux of drugs, hence contributing to overall bioavailability enhancement.


Sign in / Sign up

Export Citation Format

Share Document